ArticleClinical and experimental medicine2023

High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients.

Enrica Borsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.